Symbol | Exchange | Currency |
|---|
TXRUSD Price Analysis – August 07 In case the buyers increase their momentum and break up the resistance level of $0.082, the TRX price may increase to resistance levels of $0.100...
Leading USD-pegged stablecoin USDC is now functional on the Tron (TRX) blockchain. USDC Now Live on Tron USDC, a digital currency tied to the price of the U.S. dollar is now...
After a particularly bearish Wednesday, the majors will need to move through the day’s pivot levels to begin the recovery process.
After a mixed early part of the week, a move through the day’s pivot levels would be needed to avoid a sell-off.
Following Monday’s gains, a move back through Monday’s highs would be needed to avoid a reversal.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Buy | Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Sell | Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,002.00 | 2,070.00 | 1,982.00 | +14.00 | +0.70% | 496.46K | London | |||
| 102.90 | 110.00 | 102.90 | -2.10 | -2.00% | 358.45K | London | |||
| 1,875.00 | 1,850.00 | 1,850.00 | 0.00 | 0.00% | 0.00 | London | |||
| 360.10 | 365.55 | 357.35 | -9.80 | -2.65% | 46.51M | London | |||
| 133.92 | 135.30 | 133.50 | -1.04 | -0.77% | 16.30M | London | |||
| 34.00 | 35.00 | 33.50 | -0.50 | -1.45% | 774.42K | London | |||
| 637.80 | 645.00 | 635.20 | -8.40 | -1.30% | 1.12M | London | |||
| 7.55 | 7.55 | 7.55 | -0.10 | -1.31% | 284.81K | London | |||
| 476.00 | 487.00 | 476.00 | -7.00 | -1.45% | 1.05M | London | |||
| 60.40 | 60.60 | 59.40 | +1.14 | +1.92% | 12.29M | London | |||
| 48.40 | 49.90 | 48.40 | -0.45 | -0.92% | 908.38K | London | |||
| 117.20 | 119.20 | 116.20 | +0.40 | +0.34% | 1.78M | London | |||
| 48.00 | 48.80 | 47.85 | +1.00 | +2.13% | 356.72K | London | |||
| 4.85 | 4.85 | 4.85 | 0.0000 | 0.00% | 136.63K | London | |||
| 449.50 | 458.50 | 447.00 | -6.50 | -1.43% | 189.59K | London |
Tissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation (dCELL) technology removes deoxyribonucleic acid and other cellular material from tissue leaving an acellular scaffold, which is not rejected by the patient's body. The dCELL has applications in wound care, heart valve replacement and knee repair. Its products portfolio includes DermaPure, which is used for the treatment of chronic or acute wounds; SurgiPure XD Surgical Tissue Matrix, which is used as a soft tissue patch for the surgical repair of damaged or ruptured soft tissue membranes; OrthoPure XM, which is used to replace the tissue removed during a partial meniscopy; OrthoPure XT, which is a decellurised porcine tendon, and CardioPure, a decellurised human pulmonary or aortic heart valve.